PVLA
Palvella Therapeutics
PVLA
PVLA
97 hedge funds and large institutions have $129M invested in Palvella Therapeutics in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 27 increasing their positions, 29 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
7% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 29
1% less funds holding
Funds holding: 98 → 97 (-1)
Holders
97
Holding in Top 10
1
Calls
$107K
Puts
–
Top Buyers
| 1 | +$9.18M | |
| 2 | +$7.19M | |
| 3 | +$3.81M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$3M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$2.55M |
Top Sellers
| 1 | -$4.65M | |
| 2 | -$1.12M | |
| 3 | -$743K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$735K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$513K |